"/> Novus Biologicals™ Peptide bloquant d’anticorps ND… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps NDUFB9

Réf. : BL-RE-051118Réf. fabricant : 18269175 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
4715
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77138. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 17 amino acids near the carboxy terminus of human LYRM3.

Points forts

Source

Synthetic

(Accession #: Q9Y6M9) The NDUFB9 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-051118
Réf. fabricant18269175
Gene ID (Entrez)4715
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77138. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneB22, CI-B22, complex I B22 subunit, Complex I-B22, FLJ22885, LYR motif-containing protein 3, LYRM3DKFZp566O173, NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22 kDa, NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9, NADH-ubiquinone oxidoreductase B22 subunit, UQOR22NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22 kD, B22)
Symbole de gène(s)NDUFB9
Type de produitNDUFB9
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acids near the carboxy terminus of human LYRM3
Une question, une configuration particulière ?
Contactez-nous pour un devis.